Trudeau announces $1.1B scientific strategy to fight COVID-19

Prime Minister Justin Trudeau has announced a $1.1 billion strategy for medical research to fight COVID-19.

"The better we understand this virus, its spreadand its impact on different people, the better we can fight it and eventually defeat it," Trudeau said today.

The plan has three components:

• $115 million for research into vaccines and treatments being developed in hospitals and universities.
• $662 million for clinical trials in Canada.
• $350 million to expand national testing and modelling for COVID-19.

Trudeau also announced the creation of a new COVID-19 immunity task force focused on serology testing blood-based tests used to determine if someonehas been exposed to the virus already.

David Naylor, who chaired the committee that reviewedCanada's response to SARS in 2003, will be on the panel.

Trudeau said the task force will work to determine howmany people have COVID-19 beyond those who already havebeen tested, whether those who've recovered areimmune and, if so,how long that immunity might last.

Watch: Prime Minister Trudeau announces pandemic science strategy

Trudeau announced $1.1B scientific strategy to fight COVID-19

4 years ago

Duration 3:53

Prime Minister Justin Trudeau announced a $1.1 billion strategy to fund COVID-19 medical research and a task force to study immunity.

One million Canadians will be tested as part of the study over the next two years.

Trudeau said testing is key to the fight againstCOVID-19. He said 20,000 tests are being done every day.

"Testing must increase even further before we can reopen and restart our normal activities as a country," he said.

Trudeau also warned that once a vaccine is developed whether that happens in Canada or elsewhere in the world the global competition to produce it will be fierceand may lead to the same bottlenecks governments everywhere have experienced intrying to obtainpersonal protection equipment (PPE) for medical staff.

That's why it's important to establish the capacity to mass-producevaccines here in Canada now, he said.

Around the world, many people are losingpatience with public health guidelines that compel them to stayat home and practisephysical distancing. Trudeau said the speed at which those restrictions can be lifted will dependon the advice of scientists.

"We know it may be a long while before a vaccine. There are discussions around treatments for COVID-19 that might work as well as a vaccine," he said.

"We've been waiting for and looking for and searching for a vaccine for AIDS for decades now, and it still hasn't come, but there are treatments that mean quality of life for people."

Watch: Prime Minister Trudeau is asked when Canadians' lives can return to "normal"

Trudeau questioned about when Canadians can return to a normal life

4 years ago

Duration 2:27

Prime Minister Justin Trudeau spoke with reporters including the CBC's Julie Van Dusen on Thursday.

Scientists around the globe are scrambling to come up with tests and treatments to limit the disease and, ultimately, a vaccine to protect against the novelcoronavirus, whichhas killed nearly 2,000 Canadians and almost 200,000 people worldwide.

Canada's chief science officer Mona Nemersaid today thatserology testing checks for the antibodies that are generated in response to an infection and can tell physicians who has beeninfected without knowing it.

"Serology testing will also tell us how quickly immunity develops and also fades. And this is important in guiding our recovery strategies," she said.

"Other important information that we're still missingis how quickly the virus changes or mutates to escape detection and whether certain individuals are more susceptible to infection or less able to overcome it."

Today's measures support previous efforts by the Trudeau government to marshal Canada's scientific community in the battle against COVID-19.

In mid-March, it committed $275 million to researchas part of the first emergency aid package.

That was supplemented later in the month by the creation of a new strategic innovation fund, which provided another $192 million to specific companies and research institutions working on new drugs and vaccines.

The government also has provided $52 million through national granting councils to almost 100 research teams across the country.